Juliana's career in neuroscience began with a Ph.D. from the School of Medicine in São Paulo, Brazil. She then advanced her research at Stanford University, where she explored the neural mechanisms underlying mental health disorders, focusing particularly on the use of MDMA in the socialization of mice as a model. In 2023, Juliana transitioned to the Neuroscience Department at Yale, where she assumed an Associate Research Scientist position. Besides her research duties, Juliana is now involved in leading the iPSCs core by overseeing multiple scientific projects and supporting the rapid growth of research needs within the department.
iPSC Neurocore
Welcome to the iPSC Core Facility at the Neuroscience Department. We are committed to driving groundbreaking research by offering high standard induced pluripotent stem cells (iPSCs) and developing custom-tailored protocols designed for maximum efficiency and your needs.
Our mission is to serve as a cornerstone of support for researchers and laboratories, enhancing the quality of their work and driving impactful scientific discoveries within the Neuroscience department at Yale University. We achieve this through productive collaborations with principal investigators and their trainees, empowering them to reach new heights in research excellence.
Ongoing Research
Current Projects
- iPSC differentiation into cortical, motor and sensory neurons
- iPSC differentiation into microglia
- NGN2 insertion in iPSC cell lines
- Disease models for Alzheimer’s, Parkinson’s, and ALS
The Team
Tanina's academic journey began with a Bachelor’s degree in Biochemistry from Mouloud Mammeri University in Algeria. She then embarked on an exciting new chapter at Lille University in France, earning her PhD in January 2019. Her thesis delved into the intricate world of Extracellular Vesicles from primary microglial cells, uncovering crucial insights into their protein content. Following postdoctoral training at Johns Hopkins University, Tanina advanced her career by joining the Neuroscience Department at Yale as an Associate Research Scientist. Now, her cutting-edge research focuses on harnessing the power of induced pluripotent stem cells to model neurodegenerative diseases.